Literature DB >> 23677493

Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.

Irene M Lang1, Gérald Simonneau, Joanna W Pepke-Zaba, Eckhard Mayer, David Ambrož, Isabel Blanco, Adam Torbicki, Sören Mellemkjaer, Azzedine Yaici, Marion Delcroix.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary hypertension (IPAH) share a similar clinical presentation, and a differential diagnosis requires a thorough workup. Once CTEPH is confirmed, patients who can be safely operated have to be identified. We investigated risk factors associated with CTEPH and IPAH, and the criteria for the selection of operable CTEPH patients. This case-control study included 436 consecutive patients with CTEPH and 158 with IPAH in eight European centres, between 2006 and 2010. Conditions identified as risk factors for CTEPH included history of acute venous thromboembolism (p < 0.0001), large size of previous pulmonary embolism (p = 0.0040 in univariate analysis), blood groups non-O (p < 0.0001 in univariate analysis), and older age (p = 0.0198), whereas diabetes mellitus (p = 0.0006), female gender (p = 0.0197) and higher mean pulmonary artery pressure (p = 0.0103) were associated with increased likelihood for an IPAH diagnosis. Operability of CTEPH patients was associated with younger age (p = 0.0108), proximal lesions (p ≤ 0.0001), and pulmonary vascular resistance below 1200 dyn.s.cm⁻⁵ (p = 0.0080). Non-operable CTEPH patients tended to be less differentiable from IPAH patients by risk factor analysis than operable patients. This study confirmed the association of CTEPH with history of acute venous thromboembolism and blood groups non-O, and identified diabetes mellitus and higher mean pulmonary artery pressure as factors suggesting an IPAH diagnosis. Non-operable CTEPH is more similar to IPAH than operable CTEPH regarding risk factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677493     DOI: 10.1160/TH13-02-0097

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

1.  The Incidence and Related Risk Factors of Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism.

Authors:  Halil Tosun; Gamze Kırkıl; Figen Deveci; Necati Dağlı; Mete Özcan; Selda Telo
Journal:  Turk Thorac J       Date:  2016-04-01

Review 2.  Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series).

Authors:  Christian Gerges; Nika Skoro-Sajer; Irene M Lang
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 3.  The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism.

Authors:  Halil Doğan; Albert de Roos; Jacob Geleijins; Menno V Huisman; Lucia J M Kroft
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

Review 4.  Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Krittika Teerapuncharoen; Remzi Bag
Journal:  Lung       Date:  2022-05-29       Impact factor: 2.584

Review 5.  Chronic thromboembolic pulmonary hypertension: a review.

Authors:  Cheryl Zhiya Chong; Edgar Lik Wui Tay; Ching Hui Sia; Kian Keong Poh
Journal:  Singapore Med J       Date:  2021-07       Impact factor: 1.858

6.  Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Caio Julio Cesar Dos Santos Fernandes; Jaquelina Sonoe Ota-Arakaki; Frederico Thadeu Assis Figueiredo Campos; Ricardo de Amorim Correa; Marcelo Basso Gazzana; Carlos Vianna Poyares Jardim; Fábio Biscegli Jatene; Jose Leonidas Alves Junior; Roberta Pulcheri Ramos; Daniela Tannus; Carlos Teles; Mario Terra Filho; Daniel Waetge; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2022-06-24       Impact factor: 2.800

7.  Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico.

Authors:  Nadine Al-Naamani; Gaudalupe Espitia H; Hugo Velazquez-Moreno; Benjamin Macuil-Chazaro; Arturo Serrano-Lopez; Ricardo S Vega-Barrientos; Nicholas S Hill; Ioana R Preston
Journal:  Lung       Date:  2016-01-09       Impact factor: 2.584

Review 8.  Diabetes and Lung Disease: A Neglected Relationship.

Authors:  Jasmin Khateeb; Eyal Fuchs; Mogher Khamaisi
Journal:  Rev Diabet Stud       Date:  2019-02-25

9.  The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Manuel Jonas Richter; Katrin Milger; Sarah Haase; Natascha Sommer; Khodr Tello; Werner Seeger; Eckhard Mayer; Christoph Benjamin Wiedenroth; Friedrich Grimminger; Wolfgang George; Hossein Ardeschir Ghofrani; Stefan Guth; Henning Gall
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Tian-Xiang Chen; Bigyan Pudasaini; Jian Guo; Su-Gang Gong; Rong Jiang; Lan Wang; Qin-Hua Zhao; Wen-Hui Wu; Ping Yuan; Jin-Ming Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.